Cargando…

Propranolol efficiency in prevention of sustained ventricular tachycardia in patients with implanted cardioverter-defibrillator: a case series

Detalles Bibliográficos
Autores principales:	Puljević, Mislav, Velagić, Vedran, Puljević, Davor, Miličić, Davor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Medical Schools 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944421/ https://www.ncbi.nlm.nih.gov/pubmed/24577831 http://dx.doi.org/10.3325/cmj.2014.55.75

Ejemplares similares

Learning curves in atrial fibrillation ablation – A comparison between second generation cryoballoon and contact force sensing radiofrequency catheters
por: Velagic, Vedran, et al.
Publicado: (2020)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Feasibility and safety of reprocessing of intracardiac echocardiography catheters for electrophysiology procedures – a large single center experience
por: Velagic, Vedran, et al.
Publicado: (2023)

Epicardial Cardioverter Defibrillator Implantation due to Post-Fontan Ventricular Tachycardia
por: Papakonstantinou, Nikolaos A, et al.
Publicado: (2020)

Fluoroless vs. conventional catheter ablation of supraventricular tachycardia - retrospective single-centre analysis
por: Prepolec, I, et al.
Publicado: (2023)

Tachycardia detection in modern implantable cardioverter–defibrillators
por: Brüggemann, Thomas, et al.
Publicado: (2016)

Ventricular tachycardia prediction in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
por: Lebedeva, Viktoria K., et al.
Publicado: (2018)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
por: Mansour, Fadi, et al.
Publicado: (2019)

RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy
por: Tsukahara, Keita, et al.
Publicado: (2021)

Ventricular tachycardia as presenting arrhythmia as a determinant of appropriate implantable cardioverter-defibrillator therapy in secondary prevention
por: Noordman, A B P, et al.
Publicado: (2023)

Misinterpretation of dual atrioventricular nodal non-reentrant tachycardia as ventricular tachycardia and implantation of implantable cardioverter-defibrillator followed by inappropriate shocks
por: Türkmen, Yusuf
Publicado: (2020)

Arrhythmogenicity of anti-tachycardia pacing in patients with implantable cardioverter defibrillator
por: Awad, Sherien Samy, et al.
Publicado: (2023)

Dual tachycardia induced by electrocution terminated by an implantable cardioverter-defibrillator
por: Kocovic, Nikola, et al.
Publicado: (2023)

Ventricular Tachycardia Precipitated by Short-long-short Sequence in a Patient with Implantable-cardioverter Defibrillator
por: Chemello, Diego, et al.
Publicado: (2012)

Ventricular Tachycardia Storm in a Patient with an Implanted Cardioverter-Defibrillator Following COVID-19 Infection
por: Kasinadhuni, Ganesh, et al.
Publicado: (2022)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)
por: Aktas, Mehmet K., et al.
Publicado: (2020)

“Carryover phenomenon” in subcutaneous implantable cardioverter‐defibrillator: Residual energy caused early shock to subsequent ventricular tachycardia
por: Yamagishi, Yasunobu, et al.
Publicado: (2022)

Subcutaneous-implantable cardioverter defibrillator lead dislodgement in a juvenile catecholamine-induced polymorphic ventricular tachycardia patient
por: Miyoshi, Miwa, et al.
Publicado: (2022)

Croatia needs a registry of patients undergoing direct current cardioversion for persistent atrial fibrillation/flutter
por: Dubravčić, Mia, et al.
Publicado: (2016)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
por: Römers, Hans, et al.
Publicado: (2022)

Non-response to Implantable Cardioverter Defibrillator in a Post-Infarction Patient with Recurrent Ventricular Tachycardia After Catheter Ablation
por: Feng, Xiang-Fei, et al.
Publicado: (2015)

Somatic comorbidity, metabolic syndrome, cardiovascular risk, and CRP in patients with recurrent depressive disorders
por: Topić, Radmila, et al.
Publicado: (2013)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion
por: Honarbakhsh, Shohreh, et al.
Publicado: (2023)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators
por: Regoli, François D., et al.
Publicado: (2023)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Implantable Cardioverter-Defibrillator for Primary Prevention in Asia
por: Younis, Arwa, et al.
Publicado: (2023)

Unmappable ventricular tachycardia after an old myocardial infarction. Long-term results of substrate modification in patients with an implantable cardioverter defibrillator
por: Alzand, B. S. N., et al.
Publicado: (2011)

Thoracoscopic Left Cardiac Sympathetic Denervation for a Patient with Catecholaminergic Polymorphic Ventricular Tachycardia and Recurrent Implantable Cardioverter-Defibrillator Shocks
por: Yu, Woo-Sik, et al.
Publicado: (2015)

Anesthetic management of a child with catecholaminergic polymorphic ventricular tachycardia undergoing insertion of implantable cardioverter defibrillator : a case report
por: Omiya, Keisuke, et al.
Publicado: (2020)

Ultrasound-Guided Stellate Ganglion Radiofrequency in a Patient with Ventricular Tachycardia Sensitive to Implantable Cardioverter Defibrillator: A Case Report
por: Rahimzadeh, Poupak, et al.
Publicado: (2023)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Venoarterial extracorporeal membrane oxygenation and implantable cardioverter-defibrillator implantation in a hemodynamically unstable infant with ventricular tachycardia from multiple cardiac rhabdomyomas
por: Kieu, Victor, et al.
Publicado: (2018)

Non-linear Association Between Body Mass Index and Ventricular Tachycardia/Ventricular Fibrillation in Patients With an Implantable Cardioverter-Defibrillator or Cardiac Resynchronization Therapy Defibrillator: A Multicenter Cohort Study
por: Zhou, Bin, et al.
Publicado: (2020)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5ajkdnn37n30cvg1qmi1sqks1s